The most recent findings on COVID-19 and its impact on the human body

Lisa Allgood, Executive Presbyter for the Presbytery of Cincinnati and trained immunocytochemist will present an update on Zoom about the most recent findings on COVID-19 and its impact on the human body.

Allgood grew up in the New York City area, graduating from Rutgers University with a degree in biology. She then completed a degree in immunocytochemistry at the University of Medicine and Dentistry of New Jersey, knowing she wanted to do research rather than practice medicine.

The science of immunocytochemistry helps researchers determine which antibodies will bind to specific components in the body (proteins or antigens) to trigger an immune response that helps fight infection and build immunity.

Allgood spent 36 years in the pharmaceutical industry, first at Merck, Sharp and Dohme in New Jersey, where she ran the flow cytometry laboratories in the days before personal computers. During this time she worked in immunology and virology with boards of health on five continents, researching monoclonal antibodies, cellular activation, rhinovirus and a virus then known as HTLV3/HTLV4 — now known as HIV.

After realizing that she was way too social a person to spend the rest of her life alone in a little dark laboratory, Allgood moved into clinical research at Merck, working with researchers around the country testing potential medicines and vaccines in humans. She moved to Cincinnati in 1989 to work with Procter & Gamble as it started into over-the-counter and pharmaceutical product areas. She ended up spending 26 years running that company’s clinical and then regulatory divisions, working with the U.S. Food and Drug Administration across all OTC products. Because she had experience in both pharmaceuticals and over-the-counter products, she led the teams working on the switch of Aleve and Prilosec from prescription only to OTC.

This will be a VIRTUAL MEETING ONLY. Join us on Crowdcast in advance to save your space, or to join the day of the meeting: https://www.crowdcast.io/e/elkr-104-1?lmref=D4KclA

Don't miss it!